Your Cancer Care - Cancer News

Supportive Care

Early Palliative Care Linked with Longer Lung Cancer Survival (09/01/2010)
Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer treatment resulted in better quality of life and mood and longer survival than standard treatment alone. These results were published in the New England Journal of Medicine.

Randomized Study Does Not Support Use of Methylphenidate for Cancer-related Fatigue (08/20/2010)
The results of a Phase III study indicate that overall, long-acting methylphenidate is ineffective in the management of cancer-related fatigue. Methylphenidate may provide some benefit, however, to certain subgroups of patients, such as those with advanced cancer or severe fatigue. These findings were recently published in the Journal of Clinical Oncology.

Yoga Improves Sleep and Quality of Life (05/26/2010)
A four-week yoga program that included breathing, meditation, postures, and other techniques improved sleep and quality of life among cancer survivors. The results of this study will be presented at the 2010 annual meeting of the American Society of Clinical Oncology.

Acupuncture Relieves Pain, Improves Functioning After Neck Surgery (04/28/2010)
Acupuncture may reduce pain and improve functioning among patients with cancer who have undergone surgery to the neck, according to a study published in the Journal of Clinical Oncology.[1] As well, acupuncture may relieve xerostomia (dry mouth) among these patients.

Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (03/24/2010)
Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology.

Study Suggests Long-acting Patch that Prevents Nausea and Vomiting Can Be Given in Combination with Intravenous Medication (02/09/2010)
Use of a combination of Sancuso® (granisetron transdermal system; a patch that delivers granisetron through the skin for up to five days) and intravenous granisetron appears to be safe and feasible. This approach may provide immediate and extended management of chemotherapy-induced nausea and vomiting. The results of this Phase I clinical trial were presented at the Fifth Annual Chicago Supportive Oncology Conference.

Latest Supportive Care by Stage

Management and Prevention of Anemia

Management and Prevention of Anorexia and Weight Loss

Management and Prevention of Bone Complications

Management and Prevention of Fatigue

Management and Prevention of Mucositis

Management and Prevention of Nausea and Vomiting

Management and Prevention of Neutropenia

Management and Prevention of Thrombocytopenia

Management and Prevention of Tumor Lysis Syndrome

Pain Management